LadRx Corp (LADXD)

[RodinLP]

After sleeping and thinking about PSS presentation I don't expect a BO this Year, which is sad. Only Celgene is interested to buy Aldox to change Abraxane which licences will expire in 2024. So they have time to continue more trials, and give solution to the market against many types of cancer in the same time. It'd be a big event, but we're far from that yet.
Aldox is the key of our PPS. Orpha MS is enough to keep and pay SK in CEO position, LADR is stopped since Freiburg lab was closed, and Dr Kratz left us, plus Eric Curtis wasn't capable to find a partner to continue trials or buy out CentBio.
Regarding all positive forecast I think PPS could be close to $1 and stay around that level. (Even Cytr could go back to Nasdaq, but for PSS and SK is not confortable, IMO)
Let see market reaction this week! And waiting for the end of Winter! LOL
GLTY